Cell Free DNA Methylome for Pancreatic Cancer Early Detection |
Rayjean Hung |
Sinai Health System |
PLCO |
Jan 23, 2020 |
2019-1023 |
Helicobacter pylori strain-specific blood biomarker and lung cancer risk |
Qiuyin Cai |
Vanderbilt University Medical Center |
PLCO |
Jan 10, 2020 |
2019-1026 |
Total antioxidant capacity and pancreatic cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Zhong Guo-Chao |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Jan 8, 2020 |
PLCO-565 |
Vitamin K intake and breast, endometrial, ovarian and colorectal cancer incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial |
Kang Wang |
The First Affiliated hospital of Chongqing Medical university |
PLCO |
Jan 8, 2020 |
PLCO-566 |
Vegetarianism and chronic disease risk |
Yumie Takata |
Oregon State University |
PLCO |
Jan 8, 2020 |
PLCO-564 |
Mutational landscape of in situ breast cancers in relation to invasive breast cancers |
Clara Bodelon |
NIH |
PLCO |
Dec 27, 2019 |
2019-1017 |
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and ovarian and endometrial cancers in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Rena Jones |
National Cancer Institute |
PLCO |
Dec 27, 2019 |
2019-1010 |
Associations of Serum Trimethylamine N-oxide, Choline, Carnitine, and Betaine with Colorectal Cancer Risk |
Doratha Byrd |
Moffitt Cancer Center |
PLCO |
Dec 27, 2019 |
2019-1004 |
Graph Convolutional Networks for Cancer Diagnosis, Prognosis and Therapeutic Response Prediction |
Faisal Mahmood |
Brigham and Women's Hospital |
PLCO |
Dec 18, 2019 |
PLCOI-562 |
Instrumental variable methods in survival outcome |
Youjin Lee |
University of Pennsylvania |
PLCO |
Dec 16, 2019 |
PLCO-561 |
Blood metabolomics, smoking and lung cancer risk |
Wei Jie Seow |
National University of Singapore |
PLCO |
Dec 16, 2019 |
PLCO-558 |
Analyses using GWAS data from PLCO to evaluate genetic impact on colorectal screening and outcomes |
Wen-Yi Huang |
National Cancer Institute |
PLCO |
Dec 11, 2019 |
PLCO-560 |
Magnesium intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Guo-Chao Zhong |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Dec 11, 2019 |
PLCO-559 |
Integrating Genomics and Metabolomics to Develop Predictive Models of Prostate Cancer in Multiethnic Men |
Burcu Darst |
University of Southern California |
PLCO |
Nov 26, 2019 |
PLCO-555 |
Associations of Dietary Inflammatory and Insulinemic Potential with Risk of Cancer Development |
Fred Tabung |
The Ohio State University College of Medicine |
PLCO |
Nov 25, 2019 |
PLCO-553 |
Association of endogenous estrogens, estrogen metabolites, androgens and androgen metabolites with Ovarian Cancer |
Britton Trabert |
NIH |
PLCO |
Nov 21, 2019 |
2016-0047 |
Drinking and pre-diagnosed BMI trajectories and their impact on the mortality of upper-gastrointestinal cancers in the PLCO population. |
Jianjun Li |
Sun Yat-Sen University Caner Center |
PLCO |
Nov 13, 2019 |
PLCO-546 |
Machine Learning Application of Cancer Data Analysis |
Mochen Li |
Purdue University |
PLCO |
Nov 13, 2019 |
PLCO-552 |
Integrating AI into workflow |
akio iwase |
NucleusHealth |
PLCO |
Nov 4, 2019 |
PLCOI-542 |
Exascale Deep Learning for screening based predictive modeling for lung cancer |
Greeshma Agasthya |
Oak Ridge National Laboratory |
PLCO |
Nov 4, 2019 |
PLCOI-544 |